Oscar Health, Inc.
OSCR · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,231 | $2,028 | $523 | $1,405 |
| - Cash | $1,527 | $1,870 | $1,559 | $1,104 |
| + Debt | $300 | $299 | $298 | $0 |
| Enterprise Value | $2,003 | $457 | -$738 | $301 |
| Revenue | $9,178 | $5,863 | $4,126 | $1,921 |
| % Growth | 56.5% | 42.1% | 114.8% | – |
| Gross Profit | $9,178 | $5,863 | $4,126 | $1,921 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $89 | -$212 | -$572 | -$551 |
| % Margin | 1% | -3.6% | -13.9% | -28.7% |
| Net Income | $25 | -$271 | -$606 | -$573 |
| % Margin | 0.3% | -4.6% | -14.7% | -29.8% |
| EPS Diluted | 0.096 | -1.22 | -2.87 | -3.19 |
| % Growth | 107.8% | 57.5% | 10% | – |
| Operating Cash Flow | $978 | -$272 | $380 | -$182 |
| Capital Expenditures | -$28 | -$26 | -$29 | -$26 |
| Free Cash Flow | $950 | -$298 | $351 | -$208 |